[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Molecular Microbiology Market Survey and Trend Research 2018

September 2018 | 73 pages | ID: G35592A0C95EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Roche, Qiagen, Illumina, Abbott, BioMerieux, BioMerieux, Danaher (Cepheid), Myriad Genetics, DAAN Gene, Agilent, Genomic Health, BD, Foundation Medicine etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Molecular Microbiology Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 MOLECULAR MICROBIOLOGY MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Roche (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Qiagen (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Illumina (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Abbott (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 BioMerieux (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 BioMerieux (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Danaher (Cepheid) (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Myriad Genetics (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 DAAN Gene (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Agilent (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Genomic Health (Company Overview, Sales Data etc.)
4.12 BD (Company Overview, Sales Data etc.)
4.13 Foundation Medicine (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Molecular Microbiology Market 2012-2017, by Type, in USD Million
Table Global Molecular Microbiology Market Forecast 2018-2023, by Type, in USD Million
Table Roche Overview List
Table Molecular Microbiology Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Qiagen Overview List
Table Molecular Microbiology Business Operation of Qiagen (Sales Revenue, Cost, Gross Margin)
Table Illumina Overview List
Table Molecular Microbiology Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
Table Abbott Overview List
Table Molecular Microbiology Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)
Table BioMerieux Overview List
Table Molecular Microbiology Business Operation of BioMerieux (Sales Revenue, Cost, Gross Margin)
Table BioMerieux Overview List
Table Molecular Microbiology Business Operation of BioMerieux (Sales Revenue, Cost, Gross Margin)
Table Danaher (Cepheid) Overview List
Table Molecular Microbiology Business Operation of Danaher (Cepheid) (Sales Revenue, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Molecular Microbiology Business Operation of Myriad Genetics (Sales Revenue, Cost, Gross Margin)
Table DAAN Gene Overview List
Table Molecular Microbiology Business Operation of DAAN Gene (Sales Revenue, Cost, Gross Margin)
Table Agilent Overview List
Table Molecular Microbiology Business Operation of Agilent (Sales Revenue, Cost, Gross Margin)
Table Genomic Health Overview List
Table Molecular Microbiology Business Operation of Genomic Health (Sales Revenue, Cost, Gross Margin)
Table BD Overview List
Table Molecular Microbiology Business Operation of BD (Sales Revenue, Cost, Gross Margin)
Table Foundation Medicine Overview List
Table Molecular Microbiology Business Operation of Foundation Medicine (Sales Revenue, Cost, Gross Margin)
Table Global Molecular Microbiology Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Molecular Microbiology Sales Revenue Share, by Companies, in USD Million
Table Molecular Microbiology Demand 2012-2017, by Application, in USD Million
Table Molecular Microbiology Demand Forecast 2018-2023, by Application, in USD Million
Table Global Molecular Microbiology Market 2012-2017, by Region, in USD Million
Table Molecular Microbiology Market Forecast 2018-2023, by Region, in USD Million

LIST OF FIGURES

Figure Molecular Microbiology Industry Chain Structure
Figure Global Molecular Microbiology Market Growth 2012-2017, by Type, in USD Million
Figure Global Molecular Microbiology Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region


More Publications